Fenugreek Extract

📜 Historical Use

Fenugreek has been used as a medicinal plant for about 6,000 years, and LiverTox calls it one of the oldest medicinal plants in continuous use. The traditional indications were broad and largely unrelated to each other. NCCIH records its use in various cultures as a tonic or a laxative, as a remedy for menstrual cramps, menopause symptoms and kidney stones, and to stimulate milk production during breastfeeding. LiverTox adds the regional detail: in Chinese medicine fenugreek seeds were used as a tonic, in Indian medicine as a stimulant to lactation, and in many folk medicines as an aid to digestion and as a treatment for baldness. Alongside all of that it has been an ordinary kitchen spice, and it remains one - its maple-like flavour is why it turns up as a flavouring agent in foods, beverages and tobacco. LiverTox records the names it travels under, including alholva, bockshornklee, fenogreco, Greek clover, Greek hay, hu lu ba, methi and trigonella. What is striking, set against six millennia of use, is how short the list of things it has been shown to do actually is: of the three traditional uses NCCIH names as still promoted today - diabetes, menstrual cramps and milk supply - not one has evidence NCCIH considers good enough to reach a conclusion on.

📊 What the Research Shows

The honest summary starts with what this page is filed under. NCCIH lists fenugreek's promoted uses as diabetes, menstrual cramps and stimulating milk production during breastfeeding. Testosterone is not among them, and none of the three federal sources read here evaluates fenugreek for testosterone, libido, strength or muscle mass. On the uses that have been studied, NCCIH is blunt: there is not enough high-quality evidence to determine whether fenugreek is useful for diabetes or menstrual cramps. Research suggests it may help lower blood sugar in type 2 diabetes, but many of those studies were not of high quality, and LiverTox agrees the benefits in diabetes and hypercholesterolemia have not been proven in rigorously designed prospective trials - while noting a systematic review of five randomised trials in which cholesterol fell by 15 to 33 percent. On menstrual cramps, only a small number of studies exist, the evidence is of low quality, and the effects are uncertain. Milk supply is the best-studied use and the results are mixed. LactMed reports one meta-analysis finding a mild galactogogue effect with an unknown safety profile and another finding no good evidence that it is a galactogogue; in mothers of preterm infants, fenugreek capsules did not increase milk volume at day 4, with very low certainty evidence that they do not increase it at day 10. A trial giving 1,725 mg three times daily for 21 days found no difference in milk volume or serum prolactin. NCCIH's verdict on everything else is that the evidence is too limited for conclusions.

Take 500mg fenugreek extract (Testofen) daily with meals.

May cause maple syrup odor in sweat. GI upset in some.

⚠️ What happens if taken in excess:

The most important safety fact about fenugreek is about pregnancy, and NCCIH states it in bold: fenugreek is NOT safe for use during pregnancy in amounts greater than those found in food, and its use has been linked to increased risks of birth defects in both animals and people. Little is known about whether amounts greater than those found in food are safe while breastfeeding. In food amounts, fenugreek is believed to be safe for adults and children, and LactMed records that FDA treats it as generally recognized as safe as a flavouring; it is possibly safe for adults in larger amounts, and there is not enough information on larger-than-food amounts in children. The common side effects are digestive: diarrhoea, nausea, flatulence, vomiting and bloating. Large doses may cause a harmful drop in blood sugar. Allergic reactions occur and can be serious - LiverTox describes facial oedema, wheezing, dizziness and shock; LactMed records asthma exacerbation, one nursing mother who developed toxic epidermal necrolysis attributed to fenugreek, a 14 percent fall in serum potassium, and possible cross-reaction with chickpeas, peanuts and other legumes. The two federal sources disagree about the liver: LiverTox, last updated in 2018, scores fenugreek E, an unlikely cause of clinically apparent liver injury, while LactMed, revised in July 2026, states that liver toxicity has been reported from fenugreek alone and in herbal combinations. Adverse effects are not rare in practice - in an Australian survey, 17 percent of 421 mothers taking fenugreek reported adverse reactions, most commonly stomach cramps, nausea, dry mouth, body odour and headache.

Two named interactions come out of the sources read here, and both involve bleeding or blood sugar. LactMed states plainly that fenugreek can interact with warfarin to cause bleeding, and that caution should be used in giving high dosages to women with diabetes mellitus or those taking warfarin. LiverTox gives the reason: because of its high fibre content and its estrogenic and coumadin-like effects, fenugreek has the potential to cause herb-drug interactions particularly if taken in high doses with antiplatelet drugs and warfarin. So the two drug categories to name are warfarin specifically and antiplatelet drugs as a class - not a vague reference to blood thinners. The blood-sugar interaction is a dose question rather than a drug-specific one. LactMed puts the amount at which fenugreek may lower cholesterol and blood sugar at about 25 grams or more daily, and NCCIH warns that large doses may cause a harmful drop in blood sugar. Anyone already taking medication that lowers blood glucose is therefore stacking two glucose-lowering agents, and both sources single out people with diabetes as the group to be careful with. No source read here names a cytochrome P450 enzyme or any specific transporter for fenugreek, which is worth stating plainly rather than papering over.

1. Fenugreek seed supplementation and effects on blood glucose and lipid profiles in diabetic and non-diabetic subjects: a review — Neelakantan N et al Nutr J (2014)[PubMed ↗]